Company Profile For StemCell Pharma, Inc.
10/19/2005 5:10:11 PM
--(BUSINESS WIRE)--Today 4 million have been diagnosed in the U. S. alone as suffering from Alzheimer's disease. Of that total, approximately 2.25 million Americans are in the early (I-III) stages. Presently, there are only about five drugs approved by the FDA for treatment, with the results of these drugs being less than satisfactory. This growing crisis challenges the medical profession to look for effective ways of handling this disease.
StemCell Pharma, Inc. believes that the beneficial results of its proprietary treatment will benefit positively not only this large group of patients, but also the highly stressed families of these patients who are burdened with their care.
comments powered by